Incyte Corp. sell BMO Capital Markets
Start price
30.07.25
/
50%
€67.88
Target price
30.07.26
€51.87
Performance (%)
19.71%
Price
13.04.26
€81.26
Summary
This prediction is currently active. The SELL prediction by BMO_Capital_Markets currently has a performance of 19.71%. This prediction currently runs until 30.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | -0.172% | -0.172% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Corporation (NASDAQ: INCY) had its price target raised by analysts at BMO Capital Markets from $52.00 to $60.00. They now have an "underperform" rating on the stock.
Ratings data for INCY provided by MarketBeat